Iverhope 12mg Tablet DT contains Ivermectin 12mg, an antiparasitic agent effective against a range of parasitic infections. Ivermectin belongs to the class of macrocyclic lactones and acts by binding selectively to glutamate-gated chloride ion channels in invertebrate nerve and muscle cells, leading to paralysis and death of the parasite. This formulation is designed as a dispersible tablet, facilitating ease of administration and rapid onset of action. Iverhope is indicated for the treatment of various parasitic infestations, including strongyloidiasis, onchocerciasis, and other nematode infections. It is also employed in the management of scabies and lice infestations. The tablet should be administered orally, with dosage adjusted according to the patient’s weight and the specific parasitic condition being treated. Iverhope is generally well tolerated; however, adverse effects may include mild gastrointestinal disturbances, dizziness, and transient skin reactions. Caution is advised in patients with impaired liver function or those with a history of hypersensitivity to ivermectin. Use during pregnancy and lactation should be under medical supervision. Iverhope 12mg Tablet DT offers an effective and convenient option for the management of parasitic diseases, with its dispersible form enhancing patient compliance.